EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2
Abstract Super-enhancers or stretch enhancers (SEs) consist of large clusters of active transcription enhancers which promote the expression of critical genes that define cell identity during development and disease. However, the role of many super-enhancers in tumor cells remains unclear. This stud...
Main Authors: | Shuang Cui, Qiong Wu, Ming Liu, Mu Su, ShiYou Liu, Lan Shao, Xiao Han, Hongjuan He |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-021-03538-6 |
Similar Items
-
Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
by: Hatano Manabu, et al.
Published: (2004-11-01) -
Targeting EphA2 in cancer
by: Ta Xiao, et al.
Published: (2020-08-01) -
EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia.
by: Sara Charmsaz, et al.
Published: (2015-01-01) -
Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
by: Malgorzata Gajdzis, et al.
Published: (2020-09-01) -
Roles of EphA2 in Development and Disease
by: Renping Zhou, et al.
Published: (2013-07-01)